More generics isn't really the solution. The US actually has more generic prescriptions as a percent of total prescriptions than most developed countries and US

More generics isn't really the solution. The US actually has more generic prescriptions as a percent of total prescriptions than most developed countries and US spend on drugs as % of healthcare spend is similar to other OECD countries. The cost comes from high priced innovative meds. They are high priced bc they are expensive to develop -- $2.7b to get a drug approved per most accepted estimate. Most of that is cost of failure. So the issue is if we cut those prices we stop innovation. R&d in most disease areas has already slowed dramatically bc it's too expensive / risky